Chinese herbal medicine may improve outcomes after STEMI

CHICAGO — A drug derived from traditional Chinese medicine as an adjunct to guideline-directed therapy improved CV outcomes at 30 days and 1 year compared with placebo after revascularization, with no excess bleeding risk, a speaker reported.“Despite reperfusion and optimal medical therapy, patients with STEMI still face a high risk of in-hospital mortality, myocardial no-flow and

Traditional Chinese Medicine for adjuvant treatment of breast cancer: Taohong Siwu Decoction, Chinese Medicine

Frontiers Intervention effects of traditional Chinese medicine on stem cell therapy of myocardial infarction

Chinese Medicine Johns Hopkins Medicine

Chinese herbal remedy 'just as effective as methotrexate against arthritis

Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease

Traditional Chinese Medicine for Acute Myocardial Infarction in Western Medicine Hospitals in China

Potential traditional Chinese medicines with anti-inflammation in the prevention of heart failure following myocardial infarction, Chinese Medicine

Add-On Effect of Chinese Herbal Medicine on Mortality in Myocardial Infarction: Systematic Review and Meta-Analysis of Randomized Controlled Trials

Diabetes and Dietary Supplements: What You Need To Know

Frontiers Autophagy Modulators From Chinese Herbal Medicines: Mechanisms and Therapeutic Potentials for Asthma

Traditional Chinese medicine Tongxinluo may improve heart health

Incidence and predictors of cardiovascular outcomes after acute coronary syndrome in a population-based cohort study

The utility of traditional Chinese medicine (Shenmai) in the cardiac rehabilitation after coronary artery bypass grafting: A single-center randomized clinical trial - ScienceDirect